⬆
✘
 
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,
⌂ /Medication Instructions /
 Share

Vidisic

Check Analogs Compare Prices in pharmacies: 3.4€
Can't order it
  1. Active ingredients
  2. Pharmacological Group
  3. Analogs
  4. ATX code
  5. Indications for use
  6. Used in the treatment
  7. Contraindications of the components
  8. Side effects of the components
  9. Manufacturers of the drug
Vidisic

Active ingredients

Pharmacological Group

Ophthalmic products || Rehydrating agents

Analogs

Complete analogs for the substance

ATX code

 S01XA20 Искусственные слезы и другие индифферентные препараты.

Indications for use

 Список кодов МКБ-10.
 • H04 Болезни слезного аппарата.

Used in the treatment

Contraindications of the components

Противопоказания сarbomer.

 Гиперчувствительность.

Использование препарата сarbomer при кормлении грудью.

 Возможно, если ожидаемый эффект терапии превышает потенциальный риск для плода и ребенка.

Side effects of the components

Побочные эффекты сarbomer.

 Преходящее нарушение зрения, кратковременное ощущение покалывания, раздражение глаз.

Manufacturers (or distributors) of the drug

 
Бауш Хелс ООО
 
Dr. Gerhard Mann
 
ВАЛЕАНТ ООО
42a96bb5c8a2acfb07fc866444b97bf1
✘Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.